zenocutuzumab
merus
['nsclc', 'sclc', 'zenocutuzumab']
zenocutuzumab, her2xher3 bispecific antibody, in nrg1+ cancers .
not only in nsclc and pca --&gt; 3 patients with btc
orr 34%, dor 9,1 months
mutiple fusion partner --&gt; best to evaluate with rnaseq.
#precisionmedicine #cholangiocarcinoma #livercancer 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine